Modern Healthspan: SGLT2 Inhibitors: Longevity Therapeutics, Senolytics & Telomere Lengthening #shorts
Peer-Reviewed Research
Key Takeaways
- SGLT2 inhibitors like canagliflozin and henagliflozin may act as longevity therapeutics by clearing senescent cells and protecting DNA.
- Henagliflozin was shown in a 26-week trial to lengthen telomeres in 90% of participants, suggesting DNA protection benefits.
- These drugs are now central to the Vital-H Age Federal Aging Trials, indicating their potential for aging interventions.
Notable Quotes
“SGLT2 inhibitors like canagliflozin act as a stealth senolytic. They activate the immune system to hunt down and eliminate senescent cells.”
Bottom Line
Consider discussing SGLT2 inhibitors (like canagliflozin or henagliflozin) with a healthcare provider for potential longevity benefits, particularly their dual role in senolytic activity and telomere protection.
Explore More
- Modern Healthspan’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
- Chris Williamson: The “LooksMaxxing” Mistake - Dr Debra Soh
- Modern Healthspan: Watch This Before You Take a Weight Loss Peptide
- Michael Greger: Do Vegetarians Have More or Less Depression and Anxiety?
- Michael Greger: Friday Favorites: Does Coffee Inhibit Iron Absorption? What Are the Effects of Having Too Much Iron?
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network